These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 7656353)

  • 41. The Chiasmal Compression Index: An Integrative Assessment Tool for Visual Disturbances in Patients with Pituitary Macroadenomas.
    Avraham E; Azriel A; Melamed I; Alguayn F; Al Gawad Siag A; Aloni E; Sufaro Y
    World Neurosurg; 2020 Nov; 143():e44-e50. PubMed ID: 32562903
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Multifocal visual evoked potential recordings in compressive optic neuropathy secondary to pituitary adenoma.
    Jayaraman M; Ambika S; Gandhi RA; Bassi SR; Ravi P; Sen P
    Doc Ophthalmol; 2010 Dec; 121(3):197-204. PubMed ID: 20821036
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Visual prognostic value of the pattern electroretinogram in chiasmal compression.
    Parmar DN; Sofat A; Bowman R; Bartlett JR; Holder GE
    Br J Ophthalmol; 2000 Sep; 84(9):1024-6. PubMed ID: 10966958
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Programme choice for perimetry in neurological conditions (PoPiN): a systematic review of perimetry options and patterns of visual field loss.
    Hepworth LR; Rowe FJ
    BMC Ophthalmol; 2018 Sep; 18(1):241. PubMed ID: 30200926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sellar lesions and visual loss: key concepts in neuro-ophthalmology.
    Chiu EK; Nichols JW
    Expert Rev Anticancer Ther; 2006 Sep; 6 Suppl 9():S23-8. PubMed ID: 17004853
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Component perimetry: a fast method to detect visual field defects caused by brain lesions.
    Bachmann G; Fahle M
    Invest Ophthalmol Vis Sci; 2000 Sep; 41(10):2870-86. PubMed ID: 10967040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Macular Ganglion Cell Complex Reduction Preceding Visual Field Loss in a Patient With Chiasmal Compression With a 21-Month Follow-Up.
    Monteiro MLR
    J Neuroophthalmol; 2018 Mar; 38(1):124-127. PubMed ID: 29319560
    [No Abstract]   [Full Text] [Related]  

  • 48. [Value of visual evoked potentials (VEP) in compression of the anterior visual pathway, especially in the area of the chiasm].
    Staudacher T; Reuther R; Rittmann M; Krastel H
    Nervenarzt; 1985 Oct; 56(10):560-1. PubMed ID: 4069295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Average evoked visual potentials in optic nerve compression and their behavior after decompression].
    Korol S; Stangos N
    Arch Ophtalmol Rev Gen Ophtalmol; 1974 Mar; 34(3):209-14. PubMed ID: 4277134
    [No Abstract]   [Full Text] [Related]  

  • 50. Chiasmal syndromes.
    Foroozan R
    Curr Opin Ophthalmol; 2003 Dec; 14(6):325-31. PubMed ID: 14615635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation of blue-on-yellow visual fields with scanning confocal laser optic disc measurements.
    Teesalu P; Vihanninjoki K; Airaksinen PJ; Tuulonen A; Läärä E
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2452-9. PubMed ID: 9375562
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Retinotopic organization of the visual cortex before and after decompression of the optic chiasm in a patient with pituitary macroadenoma.
    Chouinard PA; Striemer CL; Ryu WH; Sperandio I; Goodale MA; Nicolle DA; Rotenberg B; Duggal N
    J Neurosurg; 2012 Aug; 117(2):218-24. PubMed ID: 22680245
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neuro-ophthalmologic features of pituitary tumors.
    Melen O
    Endocrinol Metab Clin North Am; 1987 Sep; 16(3):585-608. PubMed ID: 3319595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Application of visual evoked potential in the evaluation of visual field defects due to chiasmal lesions.
    Wang J; Chen BH; Tan YL
    Chin Med J (Engl); 1988 Apr; 101(4):257-62. PubMed ID: 3138084
    [No Abstract]   [Full Text] [Related]  

  • 55. [Bitemporal visual field defects caused by pituitary microadenoma].
    Gao H
    Zhonghua Yi Xue Za Zhi; 1987 Oct; 67(10):573-5. PubMed ID: 3127013
    [No Abstract]   [Full Text] [Related]  

  • 56. [Perimetry in chiasmal syndrome -Liminal and surpraliminal stimuli (author's transl)].
    Dannheim F
    Klin Monbl Augenheilkd; 1977 Sep; 171(3):468-77. PubMed ID: 200790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How robust is the optic chiasm? Perimetric and neuro-imaging correlations.
    Frisén L; Jensen C
    Acta Neurol Scand; 2008 Mar; 117(3):198-204. PubMed ID: 17868042
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vision- and health-related quality of life in patients with visual field loss after postchiasmatic lesions.
    Gall C; Lucklum J; Sabel BA; Franke GH
    Invest Ophthalmol Vis Sci; 2009 Jun; 50(6):2765-76. PubMed ID: 19117930
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inapparent visual field defects in multiple sclerosis patients.
    Vidović T; Cerovski B; Vidović DH; Cerovski J; Novak-Laus K
    Coll Antropol; 2005; 29 Suppl 1():67-73. PubMed ID: 16193681
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Criteria for early detection of temporal hemianopia in asymptomatic pituitary tumor.
    Fujimoto N; Saeki N; Miyauchi O; Adachi-Usami E
    Eye (Lond); 2002 Nov; 16(6):731-8. PubMed ID: 12439668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.